A recent study published in the Journal of Cardiothoracic and Vascular Anesthesia, has reported the effective use of non-invasive positive pressure ventilation (NPPV) in COVID-19 pneumonia patients. Luca Arcari, Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy, and colleagues found that a semi-quantitative chest CT analysis at hospital admission may accurately identify people who respond poorly to NPPV.
Coronavirus disease-19 (COVID-19) is a respiratory tract infection having a significant rate of respiratory insufficiency, mortality, hospitalization need. NPPV is an emerging efficient tool for the treatment of Coronavirus disease-19 (COVID-19) pneumonia. However, the factors that influence the failure of NPPV are still elusive. Arcari and the team aimed to investigate the relationships between semiquantitative chest computed tomography (CT) scoring and NPPV failure and mortality in patients with COVID-19 in an observational study.
For more details, check out the full story on the link below: